Though GSK is definitely not the best large-cap drugmaker to have in one's portfolio, we believe there is potential for its ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.90.

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.

Some antibody-drug conjugates may cause such significant ocular toxicity that patients have vision damage or have to stop ...

Results from the company’s Phase I trial found its prodrug, SPT-300, was well tolerated, opening the doors to a Phase IIb ...

Police Say Suspect’s Notebook Described Motive for C.E.O. Killing The man who has been charged with killing Brian Thompson was found with a notebook that detailed plans for the shooting ...

Christopher Wray Will Step Down as F.B.I. Director President-elect Trump had already signaled his intention to replace Mr. Wray with a longtime loyalist, Kash Patel. U.S. Colleges Warn Foreign ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...